Coronary events in obese hemodialysis patients before and after renal transplantation

Carregando...
Imagem de Miniatura
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Citação
CLINICAL TRANSPLANTATION, v.29, n.11, p.971-977, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
We examined the impact of obesity (BMI 30 kg/m(2), n = 357) on prognosis in 1696 hemodialysis (HD) patients before and after renal transplantation (TX). End-points were coronary events, composite cardiovascular (CV) events, and death. Obese HD patients were older (55.9 +/- 9.2 vs. 54.2 +/- 11), had more diabetes (54% vs. 40%), dyslipidemia (49% vs. 30%), altered myocardial scan (38% vs. 31%), myocardial infarction (MI) (16% vs. 10%), coronary intervention (11% vs. 7%), higher total cholesterol (186 +/- 52 vs. 169 +/- 47), and triglycerides (219 +/- 167 vs. 144 +/- 91). Obese undergoing TX had more dyslipidemia (46% vs. 31%), angina (23% vs. 14%), MI (18% vs. 5%), increased total cholesterol (185 +/- 56 vs. 172 +/- 48), and triglycerides (237 +/- 190 vs. 149 +/- 100). Obesity was independently associated with coronary events (log-rank = 0.008, HR 2.55% CI 1.27-5.11) and death (log-rank 0.046, HR 1.52, % CI 1.007-2.30) in TX but not in HD. Obese HD patients had more risk factors and ischemic heart disease, but these characteristics did not interfere with prognosis. In TX patients, obesity predicts coronary events and death.
Palavras-chave
chronic kidney disease, hemodialysis, ischemic heart disease, obesity, renal transplantation
Referências
  1. Nicoletto BB, 2014, TRANSPLANTATION, V98, P167, DOI 10.1097/TP.0000000000000028
  2. Aalten J, 2006, TRANSPLANT INT, V19, P901, DOI 10.1111/j.1432-2277.2006.00367.x
  3. Cannon RM, 2013, ANN SURG, V257, P978, DOI 10.1097/SLA.0b013e318275a6cb
  4. Gore JL, 2006, AM J TRANSPLANT, V6, P357, DOI 10.1111/j.1600-6143.2005.01198.x
  5. Johnson DW, 2002, TRANSPLANTATION, V74, P675, DOI 10.1097/01.TP.0000019424.37813.26
  6. Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303
  7. Kalantar-Zadeh K, 2005, AM J CLIN NUTR, V81, P543
  8. Lentine KL, 2008, TRANSPLANTATION, V86, P303, DOI 10.1097/TP.0b013e31817ef0f9
  9. Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026
  10. Bardonnaud N, 2012, TRANSPL P, V44, P2787, DOI 10.1016/j.transproceed.2012.09.031
  11. Modlin CS, 1997, TRANSPLANTATION, V64, P599, DOI 10.1097/00007890-199708270-00009
  12. Abbott KC, 2004, KIDNEY INT, V65, P597, DOI 10.1111/j.1523-1755.2004.00385.x
  13. Leavey SF, 1998, AM J KIDNEY DIS, V31, P997, DOI 10.1053/ajkd.1998.v31.pm9631845
  14. DEGOULET P, 1982, NEPHRON, V31, P103, DOI 10.1159/000182627
  15. Meier-Kriesche HU, 2002, TRANSPLANTATION, V73, P70, DOI 10.1097/00007890-200201150-00013
  16. DesLima JJ, 2003, HYPERTENSION, V42, P263
  17. DesLima JJG, 2012, CLIN TRANSPLANT, V26, P820
  18. DesLima JJG, 2012, NEPHROL DIAL TRANSPL, V27, P2979
  19. Jousilahti P, 1996, CIRCULATION, V93, P1372